• Investing
  • Stock
Round Table Thoughts
  • Economy
  • Editor’s Pick
Home Economy House Dems vote against bill to permanently classify fentanyl as Schedule 1 controlled substance
Economy

House Dems vote against bill to permanently classify fentanyl as Schedule 1 controlled substance

by March 9, 2023
by March 9, 2023 0 comment
Share
0
FacebookTwitterPinterestWhatsapp

Democrats on the House Energy and Commerce Committee on Wednesday voted against legislation that would permanently classify both fentanyl and fentanyl-related substances (FRS) as Schedule 1 drugs that carry the toughest penalties for trafficking and possession.

Republicans say the growing fentanyl problem in America means the U.S. should permanently treat those drugs as Schedule 1 substances in the hopes of boosting penalties and stopping their spread. In 2018, the Trump administration temporarily scheduled FRS as a Schedule 1 drug in light of the growing number of fentanyl-related deaths, and Congress has extended that temporary status a few times since then.

House Republicans argue that it’s time to permanently reclassify fentanyl and FRS, and they called up a bill to do so in the Energy and Commerce health subcommittee on Wednesday to stop what several Republicans called the poisoning of tens of thousands of American citizens.

The subcommittee approved the bill in a 17-10 vote in which every Democrat voted against it except for Rep. Angie Craig, D-Minn. Other Democrats rejected the bill after arguing that the change should be coupled with an end to mandatory minimum sentences for FRS charges.

Specifically, Democrats said FRS cases that don’t lead to death or serious bodily harm should not carry mandatory minimum sentences, and they broadly argued that Republicans need to treat the matter more like a health crisis and less like a criminal crisis.

‘Mandatory minimums should take into account whether the cases involve overdoses or serious bodily harm,’ said Rep. Anna Eshoo, D-Calif.

Another Democrat, Rep. Frank Pallone of New Jersey, said Democrats support the Biden administration’s plan to only apply mandatory minimum sentences for FRS unless an offense results in serious harm or death, and to let people sentenced to seek lower sentences if an FRS is later classified as a less-harmful drug.

‘Republicans have refused to work with us’ on those and other provisions, Pallone said.

Groups that normally support Democrats, such as the ACLU and Human Rights Watch, argued in 2021 that maintaining tough penalties related to fentanyl would ‘exacerbate pretrial detention, mass incarceration and racial disparities in the prison system, doubling down on a fear-based, enforcement-first response to a public health challenge.’

But law enforcement groups have called for tougher penalties — in 2021, the National Fraternal Order of Police called on the government to address the ‘growing illicit fentanyl overdose epidemic that has gripped this country.’

Republicans said Wednesday that the deaths of tens of thousands of people due to fentanyl mean Congress must take swift action to ensure tough penalties against fentanyl and FRS. The government attributed 106,000 fentanyl-related deaths in 2021, and Rep. Bob Latta, R-Ohio, one of the sponsors of the bill, said fentanyl and FRS have become ‘weapons of mass destruction’ that must be policed.

‘This should not be a political issue,’ Latta said. ‘It’s about addressing the largest poisoning of Americans in the history of our country and taking steps to end the scourge.’

Republicans also rejected the idea from Democrats that tough fentanyl penalties are creating unfair sentences. Rep. Dan Crenshaw, R-Texas, said the growing number of fentanyl deaths of Americans is ‘murder at this point,’ and Rep. Brett Guthrie, R-Ky., said that making fentanyl and FRS riskier to bring into the country will both reduce the deaths and lower the number of fentanyl sentences.

‘The point is you can’t die from ingesting something that was never created, nor can you be incarcerated for selling something that doesn’t exist,’ he said.

Rep. Morgan Griffith, R-Va., added that because there are tens of thousands of fentanyl analogues already in existence, it makes no sense for Congress to try to analyze each one and assess which ones might pose no harm to people. He also said the GOP meets one demand being made by Democrats, which is to make it easier for researchers to access FRS in order to study these drugs.

Pete Kasperowicz is a politics editor at Fox News Digital.

This post appeared first on FOX NEWS
You Might Also Like
  • A Key Lesson in Education Policy: You Don’t Make Peace with Termites
  • NYC Mayor Adams names former grade school teacher as ‘rat czar’
  • French parliament divided among far-left, center, far-right after elections
  • ‘It’s time to rip the band aid off!’: Former longtime Democrat lawmaker urges Biden to step aside for Harris
Share
0
FacebookTwitterPinterestWhatsapp

previous post
DHS removed just 409 of 345,000 unaccompanied child migrants since FY 2021
next post
House Republicans planning to visit Jan. 6 defendants in DC jail

You may also like

Netanyahu rejects Palestinian state in postwar scenario, prompting criticism from...

January 20, 2024

Hamas’ recent battle cry for violence against US latest in...

December 31, 2023

Yellen and rest of Bidenomics team ignore middle-class misery their...

October 10, 2023

House Republicans eye prime opportunity in Virginia after Democrat announces...

November 14, 2023

Newtown, CT school board votes to keep 2 books on...

June 3, 2023

American nonprofit tied to UNRWA sued by Oct. 7 survivors...

March 15, 2024

7 reasons to fear Kamala Harris’ radical ‘Medicare-for-all’ schemes

August 20, 2024

Chipping Away at Corporate Welfare

November 29, 2022

Democrats in Biden’s home state are leaving for the Republican...

December 28, 2023

Biden vs. Trump. Is a debate fair game to test...

June 25, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Week Ahead: NIFTY Stays In A Defined Range; Moving Past This Level Crucial For Resumption Of Upmove

      May 31, 2025
    • Breakouts, Momentum & Moving Averages: 10 Must-See Stock Charts Right Now

      May 31, 2025
    • Leadership Rotation Could Confirm Corrective Phase

      May 30, 2025
    • Run Your Stock Portfolio Like a Pro Sports Team

      May 30, 2025
    • U.S. foreign tax bill sends jitters across Wall Street

      May 30, 2025

    Popular Posts

    • 1

      Trump-era China sanctions ended by Biden may be...

      June 27, 2024 2,765 views
    • 2

      Walz’s honeymoon with China gets fresh scrutiny as...

      August 9, 2024 2,472 views
    • 3

      Biden appointee played key role in recruiting Chinese...

      June 25, 2024 2,451 views
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful...

      July 10, 2024 2,432 views
    • 5

      Harris VP pick spent years promoting research facility...

      August 29, 2024 2,308 views

    Categories

    • Economy (7,009)
    • Editor's Pick (2,106)
    • Investing (538)
    • Stock (2,582)

    Popular Posts

    • 1

      Trump-era China sanctions ended by Biden may be revived under new House GOP bill

      June 27, 2024
    • 2

      Walz’s honeymoon with China gets fresh scrutiny as Harris camp blasts ‘lying’ critics

      August 9, 2024
    • 3

      Biden appointee played key role in recruiting Chinese businesses to Delaware: ‘Longtime friends’

      June 25, 2024
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful of Chinese spy threats

      July 10, 2024
    • 5

      Harris VP pick spent years promoting research facility that collaborated with ‘Chinese military company’

      August 29, 2024

    Latest News

    • Week Ahead: NIFTY Stays In A Defined Range; Moving Past...

      May 31, 2025
    • Breakouts, Momentum & Moving Averages: 10 Must-See Stock Charts Right...

      May 31, 2025
    • Leadership Rotation Could Confirm Corrective Phase

      May 30, 2025

    Categories

    • Economy (7,009)
    • Editor's Pick (2,106)
    • Investing (538)
    • Stock (2,582)

    Disclaimer: RoundTableThoughts.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 RoundTableThoughts.com. All Rights Reserved.

    Round Table Thoughts
    • Investing
    • Stock
    Round Table Thoughts
    • Economy
    • Editor’s Pick

    Read alsox

    California Sen. Dianne Feinstein hospitalized in...

    March 3, 2023

    Kamala Harris praises gun laws in...

    October 27, 2023

    Republicans demand FBI, DHS update Congress...

    January 20, 2024
    Sign In

    Keep me signed in until I sign out

    Forgot your password?

    Password Recovery

    A new password will be emailed to you.

    Have received a new password? Login here